NASHVILLE, Tenn.--(BUSINESS WIRE)--Sheridan, the Physician Services Division of AmSurg Corp. (NASDAQ: AMSG), today announced its acquisition of Coastal Anesthesiology Consultants, P.A., which will further expand its anesthesiology services business and strengthen its presence on the east coast of Florida. Coastal provides anesthesia services for Flagler Hospital facilities in the St. Augustine, Florida, market and is comprised of over 25 providers including physicians, certified registered nurse anesthetists and anesthesiologist assistants.
Dr. Sherman Turnage, President of Coastal Anesthesiology, commented, “After extensive research to identify a national leader in hospital-based physician services who could enhance our capabilities, our leadership easily concluded that Sheridan would be our best choice as a true strategic partner. We are thrilled to join the Sheridan team and plan to leverage its formidable strengths to enhance the quality of patient care in our community.”
Coastal Anesthesiology Consultants supports both inpatient and outpatient services and is the exclusive anesthesiology services provider at Flagler Hospital facilities. Flagler Hospital is a national leader in clinical excellence and has been an established provider of medical care in St. Johns County since 1889.
Robert J. Coward, President of Physician Services, noted, “We are proud that Coastal and its providers have chosen to partner with Sheridan and look forward to helping them navigate the ever-changing healthcare environment. We believe our tools and deep experience will enhance both the excellent care they already deliver to patients and the service they provide to clients.”
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements that are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts.
In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” or “predicts,” or the negative of these words or phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. While forward-looking statements reflect the Company’s good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes. Certain risks and uncertainties related to the Company’s business are or will be described in greater detail in the Company’s filings with the SEC. The information set forth herein should be read in light of such risks.
About AmSurg and Sheridan
AmSurg’s Ambulatory Services Division acquires, develops and operates ambulatory surgery centers in partnership with physicians throughout the U.S. AmSurg’s Physician Services Division, Sheridan, provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities throughout the U.S., primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. Through these businesses as of March 31, 2015, AmSurg owned and operated 248 ASCs in 34 states and provided physician services to more than 330 healthcare facilities in 27 states, employing more than 2,900 physicians and other healthcare professionals.